Welcome to my New Blog... Pictures of Skin Cancer

Mesothelioma Cancer, Skin Cancer, Melanoma Cancer, Mesothelioma, Mesothelioma lawyer

=============================================================================

Sunday, March 9, 2008

Fwd: Small Retail: It's the inner glow that sells handblown glassybabys



---------- Forwarded message ----------
From: Search for lung cancer <rssfwd@rssfwd.com>
Date: Sat, Feb 16, 2008 at 8:08 PM
Subject: Small Retail: It's the inner glow that sells handblown glassybabys
To: mesothelioma77@gmail.com


THERE'S SOMETHING sensual and slightly improbable about glassybabys, the handblown, color-saturated tumblers that have become darlings of the design world.

Sat, 16 Feb 2008 15:26:10 GMT


Source: http://seattlepi.nwsource.com/business/351463_retail16.html?
--
 Powered by RssFwd, a service of Blue Sky Factory, Inc


Fwd: More advanced cancer seen in uninsured Americans (Reuters via Yahoo! News)



---------- Forwarded message ----------
From: Yahoo! News Search Results for lung cancer <rssfwd@rssfwd.com>
Date: Mon, Feb 18, 2008 at 10:04 AM
Subject: More advanced cancer seen in uninsured Americans (Reuters via Yahoo! News)
To: mesothelioma77@gmail.com


Uninsured Americans and those in a government health program for the poor are far more likely to have advanced diseases when diagnosed with cancer than those with private coverage, researchers said on Sunday.

Mon, 18 Feb 2008 06:30:53 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/lung+cancer/SIG=11tubscdl/*http%3A//news.yahoo.com/s/nm/20080218/hl_nm/cancer_usa_dc_1
--
 ~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc

 

Fwd: Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.



---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Sat, Feb 16, 2008 at 8:08 PM
Subject: Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
To: mesothelioma77@gmail.com


[1]Breast Cancer. 2008 Feb 15;
Nagasaki K, Miki Y

Breast cancer is considered to be relatively sensitive to chemotherapy, and multiple combinations of cytotoxic agents are used as standard therapy. Chemotherapy is applied empirically despite the observation that not all regimens are equally effective across the population of patients. Up to date clinical tests for predicting cancer chemotherapy response are not available, and individual markers have shown little predictive value. A number of microarray studies have demonstrated the use of genomic data, particularly gene expression signatures, as clinical prognostic factors in breast cancer. The identification of patient subpopulations most likely to respond to therapy is a central goal of recent personalized medicine. We have designed experiments to identify gene sets that will predict treatment-specific response in breast cancer. Taken together with our recent trial about the construction of a high-throughput functional screening system for chemo-sensitivity related genes, studies for drug sensitivity will provide rational strategies for establishment of the prediction system with high accuracy, and identification of ideal targets for drug intervention.



___
Source: http://www.hubmed.org/display.cgi?uids=18274834
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Got Green Tea? If Not, You Should



---------- Forwarded message ----------
From: Search for lung cancer <rssfwd@rssfwd.com>
Date: Sat, Feb 16, 2008 at 8:08 PM
Subject: Got Green Tea? If Not, You Should
To: mesothelioma77@gmail.com


Green tea just may be nature's best safety net against cancer, heart disease, and signs of aging.

Sat, 16 Feb 2008 13:42:30 GMT


Source: http://www.redorbit.com/news/health/1256993/got_green_tea_if_not_you_should/index.html
--
  ~
Powered by RssFwd, a service of Blue Sky Factory, Inc


Fwd: Capitol Waste Services, Inc. Pays $107,300 for Excessive Idling



---------- Forwarded message ----------
From: Search for lung cancer <rssfwd@rssfwd.com>
Date: Sat, Feb 16, 2008 at 8:08 PM
Subject: Capitol Waste Services, Inc. Pays $107,300 for Excessive Idling
To: mesothelioma77@gmail.com


Capitol Waste Services, Inc. Pays $107,300 for Excessive Idling An eastern Massachusetts waste hauler has recently paid an EPA penalty of $107,300 for exceeding the state idling limit in Massachusetts.

Sat, 16 Feb 2008 16:37:19 GMT


Source: http://envirovaluation.org/index.php/2008/02/16/capitol_waste_services_inc_pays_107_300_
--
 Powered by RssFwd, a service of Blue Sky Factory, Inc